Angiotensin I‐converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow
- 20 October 2003
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 123 (3), 539-541
- https://doi.org/10.1046/j.1365-2141.2003.04598.x
Abstract
It is proposed that a locally active, intrinsic renin-angiotensin system (RAS) exists in the bone marrow (BM) and plays a role in regulating haematopoiesis. Angiotensin II type I receptor has been detected on erythroid burst-forming unit-derived cells; its antagonist losartan and angiotensin I-converting enzyme (ACE) inhibitors can suppress erythropoiesis. The possible role of ACE/RAS in BM was investigated by evaluating ACE expression in normal BM, several myeloproliferative disorders and myelodysplasia. Immunohistochemical studies showed that erythroid elements expressed ACE protein in both normal and disturbed haematopoiesis. The presence of ACE in erythroid cells suggests another mechanism for direct ACE inhibitor activity in erythropoiesis.Keywords
This publication has 8 references indexed in Scilit:
- EXPRESSION OF ANGIOTENSIN II TYPE I RECEPTOR ON ERYTHROID PROGENITORS OF PATIENTS WITH POST TRANSPLANT ERYTHROCYTOSIS1Transplantation, 2000
- Angiotensin I-Converting Enzyme: Genotype and Disease AssociationsThe Journal of Molecular Diagnostics, 2000
- Captopril Inhibits the Proliferation of Hematopoietic Stem and Progenitor Cells in Murine Long‐Term Bone Marrow CulturesThe International Journal of Cell Cloning, 1999
- Angiotensin II stimulates proliferation of normal early erythroid progenitors.JCI Insight, 1997
- Polycythaemia vera: response to treatment with angiotensin‐converting enzyme inhibitorEuropean Journal of Haematology, 1996
- A local renin-angiotensin system in the bone marrowMedical Hypotheses, 1996
- The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting EnzymeJournal of Biological Chemistry, 1995